Hatch-Waxman act
FDA expand Paragraph IV Patent Certifications List for generic drugmakers
June 19, 2019Research and Development FDA, Hatch-Waxman act, generic drugs, generics, pharma
The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
